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IL-4 is a T cell-derived lymphokine that has multiple effects on a variety ofcells
(reviewed in reference 1). Previous reports (2, 3) have demonstrated that T helper
(Th) cells of both Thl and Th2 subtypes respond to IL-4 and IL-2 after antigenic
stimulation . Of particular interest, when IL-2 and IL-4 are added together to cul-
tures of Thl or Th2 cells, both subsets respond in a synergistic manner (3). Both
lymphokines must be present simultaneously in order for synergy to occur. These
results suggest that the pathways of IL-2- and IL-4-mediated proliferation in T cells
are interrelated, either at the level of the receptors for the respective lymphokines
and/or at the level of intracellular signaling.
In the present study, we have examined the effect ofIL-4 on the number and affinity
of IL-2 receptors (IL-2Rs) on a T cell and B cell line. Our results indicate that al-
though IL-4 does not directly compete with IL-2 for binding to IL-2Rs, preincuba-
tion of HT-2 or BCL1-3B3 cells with IL-4 for 60 min at 4°C or 37°C results in a
decrease in the number of high affinity IL-2Rs on the cell surface as demonstrated
by Scatchard analysis and by crosslinking studies with 121I-IL-2 . In addition, since
the IL-4-pretreated cells bind less IL-2, they internalize less, consistent with a reduction
(down-modulation) in the number of high affinity IL-2Rs. Taken together, these
results suggest that IL-4Rs interact with IL-2Rs and that the synergy between IL-2
and IL-4, as well as other effects of IL-4 on T cells, could result, in part, from this
interaction .
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Materials and Methods
Cell Lines.
￿
The IL-2/IL-4-responsive T cell line, HT-2 (4), was maintained in RPMI-
1640 medium containing 25 mM Hepes (Gibco Laboratories, Grand Island, NY), 10% heat-
inactivated FCS (HyClone Laboratories, Logan, UT), penicillin (100 U/ml), streptomycin
(100,ug/ml), gentamicin (10 l~g/ml), t.-glutamine (2 mM), 2-ME (50 LM), sodium pyruvate
(1 mM), nonessential amino acids (0.1 mM) and human rIL-2 (10 U/ml) (AMGen, Thou-
sand Oaks, CA). The in vitro-adapted BCL, leukemia subline, 3113 (5), was maintained in
RPMI-1640 medium containing 5% heat-inactivated FCS and supplements, as described
for the culture of HT-2 cells, with the exception of IL-2 . BCLI-3B3 cells express high affinity
IL-2Rs and show an increased proliferation and secretion of IgM when cultured with IL-2
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(6). BCL1-3B3 cells express IL-4-Rs, as evidenced by specific binding of radiolabeled rIL-4
(Fernandez-Botran, R., J. W Uhr, and E. S. Vitetta, unpublished observations).
Antibodies, Lymphokines, and Reagents.
￿
The anti-IL-4 mAb 11BIl (7) was prepared by am-
monium sulfate precipitation of hybridoma culture supernatants (SNs).' IL-4 was purified
from SNs of Con A-stimulated T-286 cells (which do not synthesize IL-2) (8, 9). IL-4 prepa-
rations lacked IL-2 and IFN-y and their stimulatory effect on HT-2 cells could be completely
inhibited by the anti-IL-4 mAb 11B11 (10). 1 U of IL-4 was defined as the reciprocal of the
dilution of SN causing 50% of the maximal stimulatory activity of a standard IL-4 prepara-
tion in the FIT-2 proliferation assay. Murine rIL-4 was generously provided by Dr. T. Mos-
mann (DNAX, Palo Alto, CA) and Drs. J. Ohara and W. Paul (National Institutes ofHealth,
Bethesda, MD); human rIL-1/3 was purchased from Cistron Technology (Pine Brook, NJ).
Murine granulocyte/monocyte colony-stimulating factor (GM-CSF) and IL-3 were purchased
from Genzyme Corp. (Boston, MA). Purified mouse anti-human IL-2 antibody, N7-21, was
kindly provided by Dr. A. Jurado (CIBA GEIGY, Basel, Switzerland). Keyhole limpet
hemocyanin (KLH) was purchased from Calbiochem-Behring Corp. (La Jolla, CA). 3,3'-
dithiobis (propionic acid N-hydroxysuccinimide ester) (DTSP) was obtained from SigmaChem-
ical Co. (St. Louis, MO).
Radiolabeled IL-2.
￿
3-1251-iodotyrosyl-rIL-2 (human) (60 FACi/l~g) was purchased from
Amersham Corp. (Arlington Heights, IL). It contained <5% free 1251-iodide and retained
>90% of its biological activity. Alternatively, human rIL-2 (AMGen) was iodinated following
the procedure described by Lowenthal et al. (11) and repurified using affinity chromatog-
raphy on anti-human IL-2-Sepharose (N7-21) and elution by 50 mM citrate/150 mM NaCl
buffer, pH 2.0, followed by immediate neutralization with Tris buffer, pH 9.0. BSA was then
added to a final concentration of 1.66 mg/ml.
The concentration of the iodinated material was determined based on its biological ac-
tivity in the HT-2 proliferation assay (10) as compared with a rIL-2 standard. Specific activity
of the iodinated material was 4 x 105 cpm/pmol.
Binding Assays.
￿
Binding of 1251-IL-2 to HT-2 and BCL1 -3B3 cells was determined using
1 x 10-
12 to 5 x 10- '° M 1251-rIL-2. Briefly, HT-2 cells were harvested at the end of their
normal culture period (3 d). At this time, little free IL-2 remains in the medium and prolifer-
ation has stopped (data not shown). After harvesting the cells, they were washed three times
with balanced salt solution (BSS)/1% FCS, resuspended in RPMI-1640/10% FCS and used
for the binding assay (BCL1 -3B3) or were further preincubated 1 h at 37°C to allow inter-
nalization of receptors still occupied by IL-2 (HT2). Cells were washed two more times and
incubated at 3-5 x 105/tube with increasing concentrations of 1251-IL-2 (1 x 10-12 to 5 x
10-1° M) in the presence or absence of a 100-fold molar excess of unlabeled IL-2 in a final
volume of 100 Al in polypropylene Eppendorf tubes. After 60 min of incubation at 4°C with
periodic shaking, the cell mixtures were overlayed onto a 0.2 ml mixture of 45% dibutyl-
phthalate (Sigma Chemical Co.) and 55% dioctyl-phthalate (Aldrich Chemical Co., Milwaukee,
WI) and centrifuged for 30 s in an Eppendorf microfuge. The tips of the tubes containing
the cell pellets were then cut off and counted. The concentration ofthe free ligand was deter-
mined by subtracting cell bound counts from total counts. Specific binding at each concen-
tration of 1251-IL-2 was calculated by subtracting the mean cpm bound in the presence of
a 100-fold excess of unlabeled IL-2 (nonspecific binding) from the mean cpm bound in its
absence (total binding). Affinity and receptor number were calculated by Scatchard analysis
(12) of the equilibrium binding data.
Internalization of"-I-IL-2.
￿
Internalization of 1251-IL-2 on control and IL-4-pretreated cells
was measured following the procedure described by Weissman et al. (13) based on the devel-
opment ofacid resistance as an indicator for internalization. Briefly, cells were preincubated
for 60 min at VC with "'I-IL-2 (2-5 x 10-1 ' M) in the presence and absence of a 100-fold
molar excess ofunlabeled IL-2. Aliquots of cells were then either maintained at 4°C or trans-
ferred to a 37°C water bath for 30 min. After recooling to 4°C, acid-resistant radioactivity
' Abbreviations used in this paper: BSS, balanced salt solution; EGF, epidermal growth factor; KLH,
keyhole limpet hemocyanin; GM-CSF, granulocyte/macrophage colony-stimulating factor; PDGF, platelet-
derived growth factor; SN, supernatant.FERNANDEZ-BOTRAN ET AL.
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was determined by resuspending aliquots of cells in two volumes of 0.5 M acetic acid/0.5
M NaCl buffer, pH 2 .0, and centrifuging and counting as described for the binding assay.
Total cell-associated radioactivity was determined similarly, except that BSS11% FCS was sub-
stituted for the low pH buffer. Specific binding was calculated by subtracting nonspecific counts
from total counts.
Crosslinking of 1251-IL-2 to High Affinity IL-2Rs.
￿
HT-2 cells prepared as described for the
binding assay were resuspended at 10' cells/ml in RPMI-1640/10% FCS and preincubated
in the absence or presence of IL-1(3 (10 U/ml), IL-2 (1 x 10- '° M, 10 U/ml) or IL-4 (50 U/ml)
for 60 min at 37°C. The lymphokines were removed by washing the cells three times in BSS11%
FCS. Cells were resuspended at 1 x 107/ml in BSS/1% FCS, and '211-IL-2 was added to a
final concentration of 5 x 10- " M. Most high affinity, but very few low affinity, IL-2Rs are
occupied at this concentration (14). After incubation at 4°C for 60 min, the cells were washed
once with PBS and the bifunctional crosslinking reagent, DTSP, was added at a finalconcen-
tration of 0.5 mM in PBS (Final DMSO concentration of 0.5%). The cells were incubated
for 30 min at 4°C and the crosslinker was inactivated and removed by washing once with
PBS containing 20 MM L-lysine (pH 7.25) and twice with PBS-azide. The cells were then
lysed by incubation in 150 pl of PBS/1% NP-40 containing PMSF (1 mM) and EDTA (2
mM) for 30 min at 4°C. The lysates were centrifuged in an Eppendorf microfuge for 5 min
in order to separate nuclei and insoluble debris. The SNs were mixed with an equal volume
of2 x Laemmli's sample buffer (15), incubated for 3 min at 100°C and subjected to SDS-PAGE
using 7.5% gels and a constant current of 25 mA. After electrophoresis, the gels were fixed
in 50% methanol, dried, and exposed to Kodak X-Omat AR film (Eastman Kodak Co., Roch-
ester, NY) with a Lightning Plus intensifying screen (DuPont Co., Wilmington, DE) at - 70°C
for 3-7 d.
Results
Synergy between IL-2 and IL-4 on HT-2 Cells.
￿
In a previous study (3) we reported
that the addition of both IL-2 and IL-4 to clones ofactivated Thl or Th2 cellsresulted
in a synergistic proliferative response. Delayed addition and "wash-out" experiments
indicated that the lymphokines had to be present simultaneously in order for syn-
ergy to occur. These findings suggested that the mechanisms involved in the sig-
naling by IL-2 and IL-4 are related. To investigate a possible biochemical basis for
this relationship, we chose to study the IL-2/IL-4-responsive, Th cell line, HT-2 (4),
because HT-2 cells express relatively high numbers of IL-4Rs (11, 16) and because
their responsiveness to IL-2 and IL-4 is not dependent upon antigenic stimulation.
We later extended our observations to a neoplastic B cell line, BCL1-3B3, which
also expresses IL-2 and IL-4 receptors (5, 6, and unpublished observations).
We first investigated whether the simultaneous addition of IL-2 and IL-4 to HT2
cells induced a synergistic proliferative response. As reported previously for clones
of Thl and Th2 cells (3), the addition of a mixture of IL-2 and IL-4 to HT-2 cells
induced a proliferative response that was greater than that observed with either lym-
phokine alone or from that calculated by adding the responses to both lymphokines
(when they were added separately) (Table I).
Effects ofIL-4 on the Expression ofIL-M.
￿
The binding of 1211- or 31S-labeled IL-
4 to a variety of cells of hemopoietic origin has been reported (11, 16-18) and this
binding was not affected by the presence of IL-2 or other lymphokines (11, 16-18).
This finding, together with the fact that the effect of IL-4 on T cell proliferation
cannot be blocked by anti-IL-2R antibodies (9, 10), suggested that IL-4Rs are different
from IL-2Rs. However, because ofprevious reports of synergy and receptor/receptor
interactions among several hormones and hemopoietic growth factors (19-21) and
the synergy between IL-2 and IL-4 observed in our studies using Th cells (3), we382
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TABLE I
Synergy between IL-2 and IL-4
HT-2 cells were cultured in 96-w plates at a density of 5 x 104 cells/ml with
the indicated concentrations of lymphokines (IL-2, IL-4) for 24 h at 37°C. The
cells were then pulsed with [3H]thymidine (1 pCi/ml) and harvested after 16 h.
Results represent the mean of triplicate experiments + SEM.
hypothesized that IL-4R/IL-2R interactions might occur in some subsets (or lines)
ofT cells. To study this possibility, we preincubated HT-2 cells with IL-4 anddeter-
mined whether the affinity and/or number ofhigh affinity IL-2Rs were altered. In
such experiments, HT-2 cells were preincubated at 4°C for 60 min with IL-2 (1 x
10- " M), with medium alone, or with either recombinant or purified IL-4 (50
U/ml). After washing away the unbound lymphokines, the affinity and number of
high affinity IL-2Rs were determined by analyses ofthe binding of1251-IL-2 to HT-2
cells under conditions that would detect mainly high affinity receptors (10- 12 Mto
5 x 10-1° M). The binding data were analyzed using a Scatchard plot (12).
Preincubation ofHT-2 cells with IL-4 resulted in adecrease in thelevels ofspecific
binding of 1251-IL-2 to such cells when compared with cells preincubated with
medium alone (control) (Fig. 1). This decrease was most pronounced at lower con-
centrations (2.5 x 10-12 to 1 x 101° M) of 1251-IL-2, where most of the specific
binding should involve high affinity receptors. The IL-4-mediated reduction in the
binding of 1251-IL-2 was always partial, even after preincubation with higher doses
of IL-4. In nine experiments, the decrease in the binding of 1251-IL-2 to HT-2 cells
after preincubation with IL-4 ranged from 20.2 to 53.0% (mean ± SD: 39.2 ±
6.7) and from 12.7 to 43.0% (mean ± SD: 28.2 ± 7.1%) when binding was mea-
sured at 1251-IL-2 concentrations of 1 x 10-11 M and 5 x 10-11 M, respectively.
In contrast, preincubation with unlabeled IL-2 (1 x 10-1° M) almost completely
inhibited subsequent binding of 1251-IL-2.
The IL-4-induced decrease in the specific binding of 1251-IL-2 to HT-2 cells was
observed irrespective ofthe source ofIL-4 (purified or recombinant) and was com-
pletely reversed ifanti-IL-4 antibody (111311) (7) was added to cells incubated with
IL-4 (results not shown). In addition, the effect ofIL-4 on binding of1251-IL-2 was
not temperature dependent, since it occurred after preincubation at either 4°C or
37°C (Fig. 1, A, B, D, E). Preincubation ofIL-4R+/IL-2R+ BCL1-3133 cells with
IL-4 at 4°C also resulted in a reduction ofthe specific binding of 1251-IL-2 (Fig. 1,
C, F).
When the binding data (Fig. 1, D-F) for HT-2 cells (preincubated at 4°C and
37°C) and BCLI-3B3 cells were analyzed by means ofa Scatchard plot, curvilinear
plots were obtained, suggesting thepresence oftwo populationsofIL-2-binding sites
Lymphokine added Units/milliliter
Proliferation of HT-2
cells (cpm/culture)
None 1,296 ± 222
IL-2 1 36,372 ± 4,277
IL-4 5 4,148 ± 313
IL-4 25 17,460 ± 1,519
IL-2 + IL-4 1 + 5 70,625 ± 5,110
IL-2 + IL-4 1 + 25 73,069 ± 11,748FERNANDEZ-BOTRAN ET AL .
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FIGURE 1 .
￿
Binding of 12-11-IL-2 to HT-2 (A, B, D, E) and BCLI-3B3 cells (C F) after preincu-
bation with IL-2 or IL-4 at 4°C (A, C D, F) or 37°C (B, E) . HT-2 or BCL I-3B3 cells (3 x 10'
cells/group) were preincubated with medium (" ), IL-4 (50 U/ml) (O) or IL-2 (0 .1 nM) (" ) for
60 min at 4°C or 37°C . The cells were washed (2 x) with BSS-l% FCS to remove the unlabeled
lymphokines and subsequently incubated at 4°C for 60 min with varying amounts of "'I-IL-2
in the presence and absence of a 100-fold excess unlabeled IL-2 as described in Materials and
Methods . Cell-bound ligand was separated from free ligand by centrifugation ofthe cells through
an oil mixture (dibutyl-phtalate/dioctyl-phtalate) . The tips of the tubes containing the cell pellets
were then cut off and counted . (A-C) The specific binding of 'III-IL-2 to cells as a function of
the free ligand concentration . (D-F) Scatchard plots from binding data obtained from A-C, respec-
tively . Graphs show the results of a representative experiment of nine performed . Percent error
was <10% for all points .
of high and low affinities as previously reported (14) . Pretreatment with IL-4 at 4°C
and 37°C affected the high affinity IL-2Rs on both HT-2 and BCLI-3B3 cells.
Linear regression analysis of points representing the high affinity sites showed that
although the slopes of the curves were not altered significantly by IL-4, their inter-
cept at the abscissa was reduced, suggesting that the effect of IL-4 was mediated
primarily by a decrease in the number of high affinity sites . Table II lists the dissoci-
TABLE 11
Effect of Preincubating Cells with IL-4 on the Dissociation Constant and
Number of High Affinity IL-2Rs on HT-2 and BCLI-3B3 Cells
' Values for the Kd and receptor number were obtained by linear regression
analysis of the Scatchard plots shown on Fig . 1, D-F.
Cells
Dissociation constant '
Control IL-4
Receptor
Control
number/cell
IL-4
K,i x 10- ~~M
HT-2 (4°C) 4 .30 4.38 2,810 1,680 (-40.2%)
HT-2 (37°C) 5 .65 7.24 2,670 1,646 (-38.4%)
BCLI-3B3 (4°C) 10.60 10.30 1,676 955 (- 43.0%)384
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ation constant (Kd) and receptor numbers obtained after Scatchard analysis of the
1251-IL-2-binding data. HT -2 cells incubated with medium alone (control) had 2,810
high affinity IL-2Rs per cell with a Kd of 4.5 x 10 -1 ' M . Preincubation with IL-4
for 60 min at VC gave a partial decrease (40%) of receptors to 1,680/cell with no
apparent change in their affinity (Kd : 4.38 x 10 -1 ' M) . Similarly, the number of
receptors and their Kd values for HT-2 cells preincubated in the absence or pres-
ence of IL-4 for 60 min at 37°C were 2,670 receptors per cell; Kd : 5 .65 x 10 - ' 1
M and 1,646 receptors per cell; Kd: 7 .24 x 10-1 ' M, respectively. Thus at both tem-
peratures, pretreatment of cells with IL-4 induced a partial decrease in the number
ofhigh affinity receptors with no appreciable change in their affinity. This phenomenon
was not confined to HT-2 cells, since preincubation of B lymphoma cells (BCL1-
3B3) with IL-4 also resulted in a partial reduction of the number, but not affinity,
of the high affinity IL-2Rs. The binding studies did not measure 1251-IL-2 binding
at doses higher than 500 pM; thus, an accurate calculation of receptor number and
Kd values for low affinity IL-2Rs could not be performed . Nonetheless, after ex-
trapolation of available data (Fig. 1) for control and IL-4-pretreated HT -2 cells, Kd
values of 1 .5-2 x 10-9 M and 3.1-3.8 x 10' receptors/cell were obtained for both
groups, suggesting that the number and/or affinity of low affinity IL-2Rs were not
appreciably affected by preincubation with IL-4.
The IL-4-mediated decrease in the specific binding of 1251-IL-2 to high affinity
IL-2Rs was relatively selective, because preincubation of HT-2 cells with other lym-
phokines, including IL-1(3, GM-CSF, and IL-3, did not affect the binding of 125I-
IL-2 (results not shown). IL-1(3 induces a synergistic proliferative response on HT-2
cells in the presence of IL-2 or IL-4, indicating that IL-1 binds to these cells (results
not shown). We do not know, however, whether GM-CSF and IL-3 synergize with
IL-2 and indeed whether our HT-2 cells express receptors for these lymphokines.
Effect of IL-4 on the Internalization of 12'I-IL-2.
￿
A number of laboratories have
reported that internalization of IL-2 is mediated exclusively through high affinity
IL-2R (13, 22-25). Therefore, we hypothesized that if pretreatment of HT-2 cells
with IL-4 results in a decrease in the number of high affinity sites, the ability of
such cells to internalize IL-2 should be diminished when compared with control
cells preincubated in medium alone. To test this prediction, HT-2 cells were prein-
cubated with medium alone, IL-4 (50 U/ml) or unlabeled IL-2 (5 x 10-1° M) for
60 min at 4°C ; the cells were washed and incubated with 1251-IL-2 (5 x 10-11 M)
for an additional hour at 4°C after which aliquots of cells were maintained at 4°C
or warmed to 37°C for 30 min. At the end of this incubation period, the cells were
cooled to 4°C and the total and acid-resistant (internalized) cell-associated radioac-
tivity was determined by washing the cells with BSSJ1°Io FCS or a high salt/low pH
buffer, respectively, followed by centrifugation through an oil cushion.
As shown in Fig. 2, preincubation of HT-2 cells with IL-4 partially decreased the
binding of 1251-IL-2 and diminished the internalization of IL-2 when they were
warmed to 37°C . Preincubation of HT-2 cells with unlabeled IL-2, on the other
hand, completely abolished specific binding and internalization of 1251-IL-2. No
1251-IL-2 was internalized by cells maintained at 4°C. Although the absolute
amount of 1251-IL-2 that was internalized after incubation at 37°C was reduced in
IL-4-pretreated cellswhen compared with controls, the amount o£ IL-2 internalized
by both groups of cells relative to the total cell-associated IL-2 was similar (33%
and 31% for control and IL-4-pretreated cells, respectively) ; suggesting that the de-creased internalization of IL-2 in IL-4-pretreated cells was a reflection of reduced
binding and not interference with the process of internalization . These results strength-
en the notion that preincubation ofHT -2 cells with IL-4 results in a decrease in
the number of high affinity IL-2Rs, thereby decreasing specific binding and inter-
nalization of IL-2 .
Crosslinking of IL-2R by 12'I-IL-2.
￿
The high affinity IL-2R is composed of at least
two different subunits, withM, of 70-75,000 (p70) and 55,000 (p55) (26-30) . Both
p70 and p55 can independently bind IL-2 with intermediate (0.5-1 x 10-9 M) and
low (N1 x 10-8 M) affinities, respectively . Together, p70 and p55 bind IL-2 with
high affinity (N1 x 10-" M) . These IL-2 subunits can be visualized by autoradi-
ography of cell lysates on SDS gels after the covalent crosslinking of 1251-IL-2 to cells
under conditions of high affinity binding (26-30) .
Scatchard analyses of the binding of 1251-IL-2 to cells after preincubation with
IL-4 at 4°C and 37°C demonstrated a decrease in the number of high affinity IL-
2Rs . Accordingly, we determined whether preincubation of HT-2 cells with IL-4
would result in a partial decrease in the density of bands corresponding to the p70
and p55 subunits of the IL-2R after SDS-PAGE of lysates of cells crosslinked with
1251-IL-2 .
As shown in Fig . 3, preincubation ofHT-2 cells with unlabeled IL-4 at 37°C fol-
FIGURE 3 .
￿
SDS-PAGE analysis ofly-
sates of HT-2 cells preincubated with
different lymphokines and crosslinked
to 1251-IL-2 . HT-2 cells (2 x 107 cells/
group) were preincubated with (B) me-
dium (control), (C) IL-4 (50 U/ml), (D)
IL-2 (0 .1 nM), or (E) IL-10 (10 U/ml)
for 60 min at 37°C in a total volume
of 1 ml . After three washes with PBS/
azide (10 mM), the cells were incubated
with 1251-IL-2 (5 x 10-11 M) for 60
min at 4°C, crosslinked with DTSP
and lysed as described in Materials and
Methods. After electrophoresis, the gel
was fixed, dried, and exposed to X-ray
film for 3-7 d . The migration of the
standards (A) is indicated . The figure
depicts one representative experiment
of four that were performed.
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10 FIGURE 2 . Internalization of 1251-IL-2 by HT-2
cells after preincubation with IL-4 . HT-2 cells were
i- e
preincubated with medium alone(control, O) or IL-4
(50 U/ml, ®) for 60 min at 4°C. After two washes
IE with BSS/1% FCS, both groupsofcells wereincubated
¢$ s (60 min at 4°C) with I~5I-IL-2 at the final concen-
tration of 5 x 10-1 t M in the presence or absence 17,
4 J-\ ofa 100-foldmolarexcess ofunlabeled IL-2 . Aliquots
S 0 0 0 ofcellswere then warmed up to 37°C or maintained
U
., at 4°C for 30 min and total and acid-resistant, cell-
Q associated radioactivity were determined by centrifu-
gation through oil, as described in Materials and
Methods. Graphs show a representative experiment
4° 37° 4° 37° 4° 37° 4° 7* C of three performed . Bars represent mean of tripli-
-Total-+ -Add Resistant- cate determinations t SD.386
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TABLE III
Scanning Densitometrry Analysis of SDS-PAGE Gels of Lysates of HT-2 Cells
Crosslinked to '25I-IL-2
HT-2 cells (2 x 107/group) were preincubated with the indicated concentration of lymphokines
for 60 min at 37°C. After three washes, the cells were incubated with 1251-IL-2, crosslinked
and lysed as described in Materials and Methods. After autoradiography ofthe gels, autoradio-
grams were scanned on a video densitometer (Bio-Rad Laboratories, Richmond, CA). Peaks
I and If correspond to the p70 and p55 subunits of the high affinity IL-2R, respectively, cross-
linked to one molecule of 1251-IL-2 (Mr = 15,000), i .e., Peak 1 (75-90 Kd); Peak 11 (50-75
Kd). Results represent the mean ± SEM of four experiments.
lowed by binding and crosslinking of 1251-IL-2 resulted in the decreased labeling
of the bands corresponding to p70 and p55 . As a positive control, preincubation
with cold IL-2 followed by crosslinking with 1251-IL-2 virtually abolished the
labeling of these two bands, whereas preincubation with IL-1/3 followed by cross-
linking with 1251-IL-2 had no effect compared with the medium control. No binding
(or bands) was observed using cells lacking high affinity IL-2Rs (data not shown).
When the bands corresponding to p70 (plus 1251-IL-2) (band I) and p55 (plus 1211-
IL-2) (band II) were scanned by densitometry, preincubation with IL-4 resulted in
a 52-56% decrease in the densities of both bands (Table III). Additional but less
distinct bands of higher Mr were also detected and their density was also decreased
by preincubation with either IL-4 or IL-2. The nature of these additional bands
is not known, but they may represent either multimers of p55 and/or p70 associated
with each other or with other surface molecules, or additional IL-2R-associated pro-
teins, such as those described recently by Saragovi and Malek (31, 32).
Discussion
The impetus for the present studies was our observation that IL-4 and IL-2 in-
duce a synergistic proliferative response in both a T cell (HT2) (3) and a B cell
(BCL1-3B3) line. In this report, evidence is presented to indicate that binding of
IL-4 to its receptor induces an interaction between IL-2Rs and IL-4Rs on both HT-
2 and BCL1-3133 cells. Preincubation of cells with IL-4 at either 4°C or 37°C
resulted in a 40-50% reduction in the number of high affinity IL-2 binding sites
and, hence, in the amount of 1251-IL-2 internalized. There was no significant change
in either the affinity of the remaining IL-2Rs or in the number or affinity of low
affinity IL-2Rs. The effect on IL-2Rs appears to be relatively selective since prein-
cubation of HT-2 cells with other lymphokines, such as IL-1(3, GM-CSF, and IL-3,
did not show any effect on the affinity and/or number of IL-2Rs.
Previous studies have shown that either IL-4 or IL-2 can support proliferation
of activated Th cell lines or clones in the absence of other lymphokines (3, 10). In
Lymphokine added
(preincubation)
Area
Peak I
(p70)
OD
Peak II
(p55)
MM
Percent
Peak I
(p70)
of control
Peak II
(p55)
Medium (control) 2 .33 ± 0.13 4 .16 t 0.30 100 100
IL-4 (50 U/ml) 1 .03 ± 0.21 2 .00 t 0.45 44.2 48.1
IL-2 (0.1 nM) 0.02 ± 0.01 0 .02 t 0.01 0.9 0.5
IL-10 (10 U/ml) 2 .30 ± 0.35 3 .92 ± 0.51 98 .7 94.2FERNANDEZ-BOTRAN ET AL.
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addition, the receptors for these two lymphokines appear to be distinct as judged
by blocking studies with anti-receptor antibodies and by their physicochemical prop-
erties (9-11, 16-18, 31-35) . Thus, antibodies to IL-2Rs do not block the effects of
IL-4 on susceptible cell populations (9, 10, 33-35). A single class of IL-4Rs with
a dissociation constant of -0.5-1 x 10-1° M has been described (11, 16-18). In con-
trast, high affinity IL-2Rs are composed of at least two different subunits (26-30),
both ofwhich bind IL-2 independently and with different association rates (36, 37).
The smaller subunit (p55) binds IL-2 with low affinity (Kd = 1 x 10-8 M), whereas
the larger subunit (p70) binds IL-2 with intermediate affinity (Kd = 0.5 x 10-9
M) . Together, the two subunits form the high affinity IL-2R (Kd = 1-5 x 10- I1 M)
which is generally responsible for internalization of IL-2 and for the induction of
a proliferative response (22-25, 38). However, p70 is able to mediate signaling and
internalization ofIL-2 in cells lacking high affinity IL-2Rs (25, 39-41). In summary,
IL-2 and IL-4, through their distinctive cell surface receptors, can independently
signal cells to proliferate. Hence, the synergy between these two lymphokines could
be explained by events taking place intracellularly or at the level of surface receptors.
The present studies suggest that interactions between the two cell surface receptors
take place and that these interactions may explain the observed synergy.
Receptor/receptor interactions have been documented in a number of hormone
receptor systems (reviewed in references 19, 20 and 21, 42-46). Thus, the addition
ofone hormone can induce a decrease in the affinity (trans-modulation) or the number
(down-modulation) of receptors for other hormones (reviewed in reference 19). For
example, addition ofplatelet-derived growth factor (PDGF) or fibroblast growth factor
to fibroblasts, can induce trans-modulation of epidermal growth factor (EGF) receptors
(reviewed in references 19 and 44). Similarly, although distinct receptors for the
different CSFs (IL-3, GM-CSF, granulocyte [G]-CSF and monocyte [M]-CSF) have
been identified on immature hematopoietic cells (reviewed in references 20 and 21),
there is evidence to suggest that there are interactions among these receptors. For
example, Walker et al. (21) have reported a hierarchical pattern of receptor down-
modulations in which the CSFs with the broadest range of activities (IL-3, GM-
CSF) downregulate the expression of receptors for the more specific cytokines (G-
CSF, M-CSF).
There are several possible mechanisms to explain the IL-4-mediated decrease in
the number of high affinity IL-2Rs: (a) IL-4 could induce an enzymatic change,
such as phosphorylation of IL-2Rs, that results in their downregulation; (b) IL-4R
and IL-2R could share a common subunit; (c) The binding of IL-4 to its receptor
could induce a direct interaction with IL-2Rs; (d) The binding of IL-4 to its receptor
could induce an IL-4R-associated molecule or cytoskeletal structure to interact with
IL-2Rs.
Larsen et al . (47) have recently reported that activators of protein kinase C, e.g.,
PMA and 1-oleoyl-2-acetyl-rac-glycerol (OAG), can downregulate high affinity IL-2Rs
on mitogen-activated human T cells; this occurs at 37°C but not at 4°C . Since the
IL-4-mediated decrease in the number of high affinity IL-2Rs occurs at both 4°C
and 37°C, this observation argues against, but does not disprove, such a mechanism.
With regard to sharing a common subunit, crosslinking experiments with labeled
IL-4 have assigned the IL-4R an Mr of 60-75 Kd (16, 17), which is close to the Mr
of the p70 subunit of the IL-2R (26-32). Scanning densitometry analysis of SDS-388
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PAGE gels from lysates of cells previously treated with IL-4 and then crosslinked
with 1251-IL-2 revealed an equivalent decrease in the density of the bands corre-
sponding to both p55 and p70 when compared with controls. These results suggest
a loss of both subunits of the high affinity IL-2R after treatment of the cells with
IL-4. Hence, if IL-4Rs interact with IL-2Rs, it is likely that this interaction involves
the p70 subunit, or the combination of the p70 and p55 subunits, but not the p55
subunit alone. The presence of p70 subunits has been recently demonstrated on
resting T cells (39, 48), which also display similar numbers of IL-4Rs (500-1,000
receptors per cell) (11, 16-18). The availability of an mAb to IL-4R or p70 could
definitively settle this issue.
We have considered the possibility that binding of IL-4 to its receptor might in-
duce a conformational change in the receptor and expose a new interaction site for
IL-2R or for another molecule that interacts with it. Indeed, crosslinking experi-
ments using 1251-IL-2 and HT2 cells reveal the presence of additional bands of
higher M, other than those corresponding to the p55 and p70 subunits of IL-2Rs.
Bands of similar M, have recently been reported by Saragovi and Malek (31, 32)
in another murine cell line (p55-transfected EL-4 cells). These results suggest that
high affinity IL-2Rs might have an even more complex subunit structure or that
the p70 and p55 subunits might be closely associated with other membrane pro-
teins. Thus, it is possible that interactions between IL-2Rs and IL-4Rs could take
place through one or more of these IL-2R-"associated" proteins.
The observation that the binding of IL-4 to its receptor is able to trigger an inter-
action with IL-2Rs, raises the possibility that IL-4 might indirectly activate cells
via IL-2Rs. Hence, some of the effects of IL-4 on T cells, such as the induction
of T cell proliferation (9, 10, 49, 50), the generation of LAK cells (51) and the gener-
ation of CTLs (52-54), could be due, at least in part, to the activation of IL-2Rs
via interactions with IL-4Rs. Preliminary studies with two sublines of HT-2 cells
that differ in their ability to proliferate in response to IL-4, have suggested that the
subline that proliferates more effectively to IL-4 undergoes a greater reduction in
the number ofhigh affinity IL-2Rs (after treatment with IL-4) when compared with
the other subline. This suggests that the ability ofIL-4 to downregulate high affinity
IL-2Rs on some cells might be related to the responsiveness of such cells to IL-4.
In conclusion, it is possible that receptor/receptor interactions are a common occur-
rence among the different lymphokine receptors and might explain why different
lymphokines can synergize or mediate seemingly identical effects on some of their
target cells.
Summary
IL-2 and IL-4 induce a synergistic proliferative response in HT-2 cells, suggesting
that IL-2Rs and IL-4Rs may interact. The purpose of this study was to examine
the effect of IL-4 on the expression and function of IL-2Rs. Preincubation of HT-2
and BCL1-3B3 cells with IL-4 for 60 min at 4°C or 37°C resulted in a partial de-
crease in the number, but not the affinity of high affinity IL-2Rs as evidenced by
Scatchard analysis of binding data. The decrease in the number of high affinity
receptors correlated with decreased internalization of IL-2. Afterpreincubation with
IL-4, crosslinking of 1251-IL-2 to high affinity IL-2Rs also demonstrated a -50% re-
duction in the number of high affinity IL-2Rs. Another lymphokine, IL-1, which actsFERNANDEZ-BOTRAN ET AL.
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on HT-2 cells, had no measurable effect on the affinity or number of IL-2Rs. Taken
together, these results indicate that IL-4 downregulates the expression ofhigh affinity
IL-2Rs on some cells. It is not known whether this occurs by a direct ligand-mediated
receptor interaction, by the sharing ofa common receptor subunit, or by interaction
of the two receptors with another membrane molecule or cytoskeletal component.
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